Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px
Document › Details

Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège.

Organisations Organisation Hyloris Pharmaceuticals S.A.
  Organisation 2 Euronext Brussels
  Group Euronext (Group)
Products Product pharmaceutical
  Product 2 investment banking
Index term Index term Hyloris Pharmaceuticals–SEVERAL: investment, 202006 IPO $65.2m at $12/share at Euronext Brussels
Persons Person Van Rompay, Stijn (Hyloris Pharmaceuticals 202004 CEO + Co-Founder)
  Person 2 Jeanmart, Patrick (Hyloris Pharmaceuticals 202004– CFO acting through PaJe SRL before Degroof Petercam + Celyad + IBA)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for Hyloris Pharmaceuticals S.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top